Apheresis in three dogs weighing <14 kg

Lysa P. Posner, Jennifer Willcox, Steven E. Suter

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

History: CaridianBCT apheresis machines require a ~285 mL priming volume (extracorporeal blood) that is withdrawn from the patient in ~10 minutes. Therefore, apheresis in dogs has generally been limited to dogs > ~20 kg to assure <20% of the blood volume is removed in the priming phase. Animals/physical examination: Three dogs weighing <14 kg (13.6, 10.5, and 9.9 kg) with lymphoma that underwent apheresis. Management: The dogs were premedicated for placement of apheresis catheters with hydromorphone (0.1 mg kg-1) IM. Anesthesia was induced with propofol, to effect, intravenously and general anesthesia was maintained with isoflurane in oxygen. Following catheter placement, dogs were allowed to recover from isoflurane but were kept sedated with either a dexmedetomidine constant rate infusion (CRI) or a propofol CRI. Real time autologous blood priming was not performed in any of the dogs. Instead, priming solutions were composed of a combination of hetastarch, lactated Ringer's solution, and/or autologous blood that was harvested 4 days before the procedure. During apheresis, dogs received anticoagulant citrate-dextrose, solution-A (ACD-A) to prevent clotting and 10% calcium gluconate as needed to maintain normal ionized calcium concentrations. Dogs were monitored for cardiovascular and cardiopulmonary stability, anemia and lactic acidosis. Follow-up: All of the dogs had cardiovascular and cardiopulmonary values within clinically acceptable ranges. Immediately following apheresis all of the dogs were mildly to moderately anemic (PCV; 17-35%) although none of the dogs required a transfusion or had an increased lactate concentration. Conclusions: Dogs as small as 9.9 kg can successfully undergo apheresis with a variety of priming solutions. Dexmedetomidine or propofol given as a CRI provides sufficient sedation for this procedure.

Original languageEnglish (US)
Pages (from-to)403-409
Number of pages7
JournalVeterinary Anaesthesia and Analgesia
Volume40
Issue number4
DOIs
StatePublished - Jan 1 2013
Externally publishedYes

Fingerprint

Blood Component Removal
Dogs
dogs
Propofol
dexmedetomidine
Dexmedetomidine
blood volume
Isoflurane
isoflurane
Blood Volume
catheters
anesthesia
Catheters
Hydroxyethyl Starch Derivatives
Hydromorphone
Calcium Gluconate
Lactic Acidosis
anticoagulants
blood
sedation

Keywords

  • Apheresis
  • Chemical restraint
  • Dog
  • Fluid therapy

ASJC Scopus subject areas

  • veterinary(all)

Cite this

Apheresis in three dogs weighing <14 kg. / Posner, Lysa P.; Willcox, Jennifer; Suter, Steven E.

In: Veterinary Anaesthesia and Analgesia, Vol. 40, No. 4, 01.01.2013, p. 403-409.

Research output: Contribution to journalArticle

Posner, Lysa P. ; Willcox, Jennifer ; Suter, Steven E. / Apheresis in three dogs weighing <14 kg. In: Veterinary Anaesthesia and Analgesia. 2013 ; Vol. 40, No. 4. pp. 403-409.
@article{7fe43dff639e4ec5a28970b9998ba1d4,
title = "Apheresis in three dogs weighing <14 kg",
abstract = "History: CaridianBCT apheresis machines require a ~285 mL priming volume (extracorporeal blood) that is withdrawn from the patient in ~10 minutes. Therefore, apheresis in dogs has generally been limited to dogs > ~20 kg to assure <20{\%} of the blood volume is removed in the priming phase. Animals/physical examination: Three dogs weighing <14 kg (13.6, 10.5, and 9.9 kg) with lymphoma that underwent apheresis. Management: The dogs were premedicated for placement of apheresis catheters with hydromorphone (0.1 mg kg-1) IM. Anesthesia was induced with propofol, to effect, intravenously and general anesthesia was maintained with isoflurane in oxygen. Following catheter placement, dogs were allowed to recover from isoflurane but were kept sedated with either a dexmedetomidine constant rate infusion (CRI) or a propofol CRI. Real time autologous blood priming was not performed in any of the dogs. Instead, priming solutions were composed of a combination of hetastarch, lactated Ringer's solution, and/or autologous blood that was harvested 4 days before the procedure. During apheresis, dogs received anticoagulant citrate-dextrose, solution-A (ACD-A) to prevent clotting and 10{\%} calcium gluconate as needed to maintain normal ionized calcium concentrations. Dogs were monitored for cardiovascular and cardiopulmonary stability, anemia and lactic acidosis. Follow-up: All of the dogs had cardiovascular and cardiopulmonary values within clinically acceptable ranges. Immediately following apheresis all of the dogs were mildly to moderately anemic (PCV; 17-35{\%}) although none of the dogs required a transfusion or had an increased lactate concentration. Conclusions: Dogs as small as 9.9 kg can successfully undergo apheresis with a variety of priming solutions. Dexmedetomidine or propofol given as a CRI provides sufficient sedation for this procedure.",
keywords = "Apheresis, Chemical restraint, Dog, Fluid therapy",
author = "Posner, {Lysa P.} and Jennifer Willcox and Suter, {Steven E.}",
year = "2013",
month = "1",
day = "1",
doi = "10.1111/vaa.12026",
language = "English (US)",
volume = "40",
pages = "403--409",
journal = "Veterinary Anaesthesia and Analgesia",
issn = "1467-2987",
publisher = "Wiley-Blackwell",
number = "4",

}

TY - JOUR

T1 - Apheresis in three dogs weighing <14 kg

AU - Posner, Lysa P.

AU - Willcox, Jennifer

AU - Suter, Steven E.

PY - 2013/1/1

Y1 - 2013/1/1

N2 - History: CaridianBCT apheresis machines require a ~285 mL priming volume (extracorporeal blood) that is withdrawn from the patient in ~10 minutes. Therefore, apheresis in dogs has generally been limited to dogs > ~20 kg to assure <20% of the blood volume is removed in the priming phase. Animals/physical examination: Three dogs weighing <14 kg (13.6, 10.5, and 9.9 kg) with lymphoma that underwent apheresis. Management: The dogs were premedicated for placement of apheresis catheters with hydromorphone (0.1 mg kg-1) IM. Anesthesia was induced with propofol, to effect, intravenously and general anesthesia was maintained with isoflurane in oxygen. Following catheter placement, dogs were allowed to recover from isoflurane but were kept sedated with either a dexmedetomidine constant rate infusion (CRI) or a propofol CRI. Real time autologous blood priming was not performed in any of the dogs. Instead, priming solutions were composed of a combination of hetastarch, lactated Ringer's solution, and/or autologous blood that was harvested 4 days before the procedure. During apheresis, dogs received anticoagulant citrate-dextrose, solution-A (ACD-A) to prevent clotting and 10% calcium gluconate as needed to maintain normal ionized calcium concentrations. Dogs were monitored for cardiovascular and cardiopulmonary stability, anemia and lactic acidosis. Follow-up: All of the dogs had cardiovascular and cardiopulmonary values within clinically acceptable ranges. Immediately following apheresis all of the dogs were mildly to moderately anemic (PCV; 17-35%) although none of the dogs required a transfusion or had an increased lactate concentration. Conclusions: Dogs as small as 9.9 kg can successfully undergo apheresis with a variety of priming solutions. Dexmedetomidine or propofol given as a CRI provides sufficient sedation for this procedure.

AB - History: CaridianBCT apheresis machines require a ~285 mL priming volume (extracorporeal blood) that is withdrawn from the patient in ~10 minutes. Therefore, apheresis in dogs has generally been limited to dogs > ~20 kg to assure <20% of the blood volume is removed in the priming phase. Animals/physical examination: Three dogs weighing <14 kg (13.6, 10.5, and 9.9 kg) with lymphoma that underwent apheresis. Management: The dogs were premedicated for placement of apheresis catheters with hydromorphone (0.1 mg kg-1) IM. Anesthesia was induced with propofol, to effect, intravenously and general anesthesia was maintained with isoflurane in oxygen. Following catheter placement, dogs were allowed to recover from isoflurane but were kept sedated with either a dexmedetomidine constant rate infusion (CRI) or a propofol CRI. Real time autologous blood priming was not performed in any of the dogs. Instead, priming solutions were composed of a combination of hetastarch, lactated Ringer's solution, and/or autologous blood that was harvested 4 days before the procedure. During apheresis, dogs received anticoagulant citrate-dextrose, solution-A (ACD-A) to prevent clotting and 10% calcium gluconate as needed to maintain normal ionized calcium concentrations. Dogs were monitored for cardiovascular and cardiopulmonary stability, anemia and lactic acidosis. Follow-up: All of the dogs had cardiovascular and cardiopulmonary values within clinically acceptable ranges. Immediately following apheresis all of the dogs were mildly to moderately anemic (PCV; 17-35%) although none of the dogs required a transfusion or had an increased lactate concentration. Conclusions: Dogs as small as 9.9 kg can successfully undergo apheresis with a variety of priming solutions. Dexmedetomidine or propofol given as a CRI provides sufficient sedation for this procedure.

KW - Apheresis

KW - Chemical restraint

KW - Dog

KW - Fluid therapy

UR - http://www.scopus.com/inward/record.url?scp=84879185317&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84879185317&partnerID=8YFLogxK

U2 - 10.1111/vaa.12026

DO - 10.1111/vaa.12026

M3 - Article

C2 - 23448317

AN - SCOPUS:84879185317

VL - 40

SP - 403

EP - 409

JO - Veterinary Anaesthesia and Analgesia

JF - Veterinary Anaesthesia and Analgesia

SN - 1467-2987

IS - 4

ER -